• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Dynamic revenues nearly cut in half

Article

Dynamic revenues nearly cut in halfDynamic Healthcare Technologies blamed slow market reaction to new product introductions and continued delays in sales cycles for a disappointing first quarter. Revenues declined during the period by 44%.For

Dynamic revenues nearly cut in half

Dynamic Healthcare Technologies blamed slow market reaction to new product introductions and continued delays in sales cycles for a disappointing first quarter. Revenues declined during the period by 44%.

For the quarter (end-March), revenues were $6 million, compared with $10.7 million reported in the 1997 first quarter. The Maitland, FL-based company had a net loss of $2.9 million, compared with net income of $3 million in the same period last year.

Dynamic is experiencing prolonged sales cycles and contract closings, a trend the company believes is temporary. In addition, the company was hurt by a time lag between implementation of its new technology at initial sites and the ability of those sites to demonstrate the value of the technology, according to the company.

In any event, Dynamic is in the midst of a corporate streamlining and functional reorganization plan, which the company expects will result in a number of benefits such as more cost-effective operations and consistent delivery of products and solutions. The plan, which has a cost-reduction target of 20%, will continue through the second quarter.

In other company news, Dynamic has signed a loan commitment from a commercial bank for a $5 million revolving line of credit and a $200,000 guidance line of credit. The lender's obligation to close on the two lines of credit is conditioned upon conducting a satisfactory pre-closing audit and a company infusion of cash equity of $2.8 million on terms satisfactory to the lender.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.